The Valley Desk

NCT02365766 · Interventional trial

Neoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC Subjects

Overall registry status Completed

Phase 1 · Phase 2

Conditions Bladder Cancer, Urothelial Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov